These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35870133)

  • 1. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease.
    Mahapatra G; Gao Z; Bateman JR; Lockhart SN; Bergstrom J; DeWitt AR; Piloso JE; Kramer PA; Gonzalez-Armenta JL; Amick KA; Casanova R; Craft S; Molina AJA
    Alzheimers Dement; 2023 Apr; 19(4):1466-1478. PubMed ID: 35870133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer's dementia.
    Amick KA; Mahapatra G; Gao Z; Dewitt A; Craft S; Jain M; Molina AJA
    Front Aging Neurosci; 2022; 14():954090. PubMed ID: 36212044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.
    Silva DF; Selfridge JE; Lu J; E L; Roy N; Hutfles L; Burns JM; Michaelis EK; Yan S; Cardoso SM; Swerdlow RH
    Hum Mol Genet; 2013 Oct; 22(19):3931-46. PubMed ID: 23740939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Blood Cells From Older Adults Exhibit Sex-Associated Differences in Mitochondrial Function.
    Mahapatra G; Gao Z; Bateman JR; Lockhart SN; Bergstrom J; Piloso JE; Craft S; Molina AJA
    J Gerontol A Biol Sci Med Sci; 2024 May; 79(5):. PubMed ID: 38602189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Delbarba A; Abate G; Prandelli C; Marziano M; Buizza L; Arce Varas N; Novelli A; Cuetos F; Martinez C; Lanni C; Memo M; Uberti D
    Oxid Med Cell Longev; 2016; 2016():5923938. PubMed ID: 26881032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-cell bioenergetics are associated with physical function and inflammation in overweight/obese older adults.
    Tyrrell DJ; Bharadwaj MS; Van Horn CG; Marsh AP; Nicklas BJ; Molina AJ
    Exp Gerontol; 2015 Oct; 70():84-91. PubMed ID: 26226578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle.
    Morris JK; McCoin CS; Fuller KN; John CS; Wilkins HM; Green ZD; Wang X; Sharma P; Burns JM; Vidoni ED; Mahnken JD; Shankar K; Swerdlow RH; Thyfault JP
    Function (Oxf); 2021; 2(6):zqab045. PubMed ID: 34661111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective mitochondrial respiration, altered dNTP pools and reduced AP endonuclease 1 activity in peripheral blood mononuclear cells of Alzheimer's disease patients.
    Maynard S; Hejl AM; Dinh TS; Keijzers G; Hansen ÅM; Desler C; Moreno-Villanueva M; Bürkle A; Rasmussen LJ; Waldemar G; Bohr VA
    Aging (Albany NY); 2015 Oct; 7(10):793-815. PubMed ID: 26539816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities are positively associated with cortical thickness in Alzheimer's disease.
    Jacobs HI; Clerx L; Gronenschild EH; Aalten P; Verhey FR
    J Alzheimers Dis; 2014; 39(2):409-22. PubMed ID: 24169238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased deoxythymidine triphosphate levels is a feature of relative cognitive decline.
    Desler C; Frederiksen JH; Angleys M; Maynard S; Keijzers G; Fagerlund B; Mortensen EL; Osler M; Lauritzen M; Bohr VA; Rasmussen LJ
    Mitochondrion; 2015 Nov; 25():34-7. PubMed ID: 26408413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.